On the recordMay 8, 2007
Although I was unable to be present for these two votes, I would like to state for the record how I would have voted. I would have opposed Senator Cochran's amendment which requires the Secretary of HHS to certify that drug importation would not pose any safety risk to consumers. As a matter of practice, the Secretary is not able to certify that any drug from any facility, here in the United States or abroad, would not pose a safety risk. As such, this amendment effectively would block the implementation of Senator Dorgan's amendment. The fact that the Cochran amendment passed is unfortunate. It is unconscionable that Americans are paying on average twice as much for lifesaving drugs as citizens of other countries, and our State and Federal health programs are struggling to bear these costs. Finally, my HELP Committee colleagues have spent months negotiating and drafting the Prescription Drug User Fee Amendment Act, which contains a number of critical reauthorizing and drug safety provisions.
Source
govinfo.gov




